CareDx, Inc. vs. Quest Diagnostics Inc.
Quest Diagnostics Inc. (DGX) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CDNA | DGX | |
|---|---|---|
| Market Cap | $2.81 billion | $27.31 billion |
| Revenue (TTM) | — | $11.56 billion |
| Net Income (TTM) | — | $1.11 billion |
DGX leads on 1 of 1 size & scale factors.
Valuation
| CDNA | DGX | |
|---|---|---|
| P/E Ratio | — | 26.16 |
| Price / Book | — | 3.49 |
| Price / Sales | — | 2.36 |
CDNA and DGX split the valuation factors evenly.
Profitability
| CDNA | DGX | |
|---|---|---|
| Net Margin | — | 9.63% |
| Return on Equity | — | 14.23% |
CDNA and DGX split the profitability factors evenly.
Dividend
| CDNA | DGX | |
|---|---|---|
| Dividend Yield | — | 1.40% |
| Payout Ratio | — | 36.52 |
CDNA and DGX split the dividend factors evenly.
Risk & Sentiment
| CDNA | DGX | |
|---|---|---|
| Short Interest | 7.55% | 4.76% |
DGX leads on 1 of 1 risk & sentiment factors.
Dig deeper: CDNA overview, CDNA financials, DGX overview, DGX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.